Published in ISRN Neurol on May 26, 2011
Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol (2013) 1.21
Genetic factors moderate everyday physical activity effects on executive functions in aging: Evidence from the Victoria Longitudinal Study. Neuropsychology (2016) 0.77
Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats. PLoS One (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Oxidants, oxidative stress and the biology of ageing. Nature (2000) 23.21
A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A (1975) 15.35
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science (2002) 6.35
Rates of behavior and aging specified by mitochondrial function during development. Science (2002) 6.28
A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet (2002) 6.26
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A (2003) 5.44
Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem (2008) 5.22
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes (2002) 4.97
Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol (1977) 4.42
Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology (2007) 4.14
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron (2003) 4.11
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis (2005) 3.78
Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol (2004) 3.67
Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet (2007) 3.59
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology (2004) 3.47
The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol (1998) 3.45
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
Cognitive dysfunction and diabetes mellitus. Endocr Rev (2008) 3.17
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol (2009) 3.13
Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A (2002) 3.04
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Cognition and diabetes: a lifespan perspective. Lancet Neurol (2008) 2.96
Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes (2003) 2.90
Tau protein function in living cells. J Cell Biol (1986) 2.89
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology (2005) 2.74
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A (2004) 2.54
The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol (2004) 2.47
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes (1999) 2.41
Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci (2000) 2.37
Insulin increases CSF Abeta42 levels in normal older adults. Neurology (2003) 2.27
Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging (2005) 2.11
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci (2003) 2.03
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A (2003) 2.02
Appetite control. J Endocrinol (2005) 1.97
Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord (2002) 1.95
Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci (2001) 1.95
Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem (1997) 1.88
Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev (2000) 1.85
Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem (1999) 1.77
A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes (2000) 1.73
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging (2005) 1.68
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J Biol Chem (2002) 1.62
(Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta (2008) 1.59
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry (1999) 1.57
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem (1999) 1.52
Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol (2003) 1.50
The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci (1999) 1.50
Insulin and the blood-brain barrier. Curr Pharm Des (2003) 1.49
Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev (1989) 1.48
Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes (2000) 1.48
Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res (2000) 1.46
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol (2003) 1.44
Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci (2003) 1.43
Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J Biol Chem (1997) 1.43
Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care (1997) 1.39
Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav (2000) 1.36
The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol (2000) 1.34
Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol Aging (2006) 1.32
Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology (2004) 1.29
In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. Development (2000) 1.29
Glucose metabolism and hyperglycemia. Am J Clin Nutr (2008) 1.26
The pathology of "vascular dementia": a critical update. J Alzheimers Dis (2008) 1.25
Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat (2004) 1.25
Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol (2008) 1.25
Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J (2000) 1.23
Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab (1987) 1.22
Insulin: new roles for an ancient hormone. Eur J Clin Invest (1999) 1.22
Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem (2001) 1.22
Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev (2007) 1.18
Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care (2007) 1.10
Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry (2005) 1.10
Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem (2004) 1.09
Diabetes as a risk factor for stroke. A population perspective. Diabetologia (1995) 1.05
Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int J Biochem Cell Biol (2003) 1.04
Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J Neurochem (2005) 1.04
Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides (1990) 1.04
Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience (2000) 1.03
Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures. Neurosci Lett (1995) 1.02
Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes. Endocrinology (2000) 1.01
Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord (2008) 0.99
Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease. Curr Alzheimer Res (2004) 0.98
Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol (1999) 0.97
The role of tau in Alzheimer's disease. Med Clin North Am (2002) 0.97
Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes (2005) 0.97
The cellular and physiological actions of insulin in the central nervous system. Neurochem Int (1993) 0.96
Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol Aging (2006) 0.93
Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J Diabetes Complications (2008) 0.91
Risk factors for vascular dementia: a review. Dementia (1994) 0.91
The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res (2005) 0.90
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry (2006) 0.89
Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiol Aging (2006) 0.87
(Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta (2008) 1.59
Inverse relationship between depressive symptoms and arterial blood pressure in community-dwelling oldest-old Brazilians. J Am Geriatr Soc (2013) 1.39
Lower mortality from H1N1 influenza in older Argentineans: men more affected. J Am Geriatr Soc (2010) 1.01
Neuropsychological performance in DSM-IV ADHD subtypes: an exploratory study with untreated adolescents. Can J Psychiatry (2002) 0.96
Dengue and primary care: a tale of two cities. Bull World Health Organ (2010) 0.90
Acculturation, obesity, and hypertension among female Brazilian Indians. Hypertension (2010) 0.81
The demands of family caregivers of elderly individuals with dementia. Rev Esc Enferm USP (2010) 0.79
[Tendencies of studies addressing the eldest individuals of aged population in the community: a (inter)national systematic review]. Rev Esc Enferm USP (2011) 0.77
On the Brazilian elderly Amerindian heritage and the Very Old Italian-Brazilian Longitudinal Study on Aging. J Am Geriatr Soc (2006) 0.75
Reasons for the high competitiveness in entering a geriatrics fellowship in Brazil: some comparisons with the United States. J Am Geriatr Soc (2006) 0.75
Socioeconomic and health differentials between two community-dwelling oldest-old groups. Rev Saude Publica (2011) 0.75
Age, social stratum, and obesity in Latin America: similarities in the inequalities for older people. J Am Geriatr Soc (2006) 0.75
Medical complaints and psychosocial and cultural characteristics of a nationwide sample of 2,136 community-dwelling Brazilian elderly people: the Fundação Perseu Abramo project. J Am Geriatr Soc (2008) 0.75
Absence of dementia in the oldest ever reported monozygotic twins: genetics, lifestyle, or chain of probabilities? J Am Geriatr Soc (2011) 0.75
Is culture an independent variable in psychogeriatrics? The case of Japanese and Brazilian elderly. Int Psychogeriatr (2006) 0.75
High prevalence of diabetes mellitus in older people in a rural area in Laos. J Am Geriatr Soc (2006) 0.75